We are enrolling 1,500 children between 18 and 48 months of age in the Children’s Autism Metabolome Project (CAMP).

The study will include children with autism spectrum disorder and other developmental delays, as well as typically developing children. The design of the study will enable us to confirm previously discovered biomarkers, expand the biomarker profiles for metabolic subtypes, and optimize the test accuracy by creating panels of biomarker subtypes that will better diagnose this heterogeneous syndrome.

General Information

Study Details

UC-Davis MIND Institute

2825 50th St
Sacramento, CA 95817
CAMP Study Information
David Amaral – Principal Investigator
Erika Bickel – Study Coordinator

Nationwide Children’s Hospital

700 Children’s Drive
Columbus, OH 43205
Daniel Coury – Principal Investigator
Melissa Brown – Study Coordinator

Massachusetts General Hospital

Lurie Center for Autism
1 Maguire Road
Lexington, MA 02421
Ann Neumeyer – Principal Investigator
Jennifer Mullett – Site Coordinator

Melmed Center

4848 E Cactus Road, Suite #940
Scottsdale, AZ 85254
Raun Melmed – Principal Investigator
Craig Ciuk – Study Coordinator

Monroe Carell, Jr. Children’s Hospital at Vanderbilt

2200 Children’s Way
Nashville, TN 37232
Allyson Cundiff – Principal Investigator
Sarah Marler – Study Coordinator

Children’s Hospital of Philadelphia (CHOP)

34th Street and Civic Center Boulevard
Philadelphia, PA 19104
Amanda Bennett-Palladino – Principal Investigator
Vaikunt Ranganathan – Site Coordinator

Arkansas Children’s Research Hospital

13 Children’s Way
Little Rock, AR 72202
Richard Frye – Principal Investigator
Robin Gibson – Study Coordinator

Cincinnati Children’s Hospital Medical Center

3333 Burnet Ave
Cincinnati, OH 45229
Logan Wink – Principal Investigator
Sophia Melnyk – Study Coordinator

(608) 204-0104

504 S. Rosa Rd. Suite 150
Madison, WI 53719